1.Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma.
Ping SONG ; Zhi-Ming AN ; Xiao-Gang ZHOU ; Feng LI ; Li-Ping WANG ; Qian ZHAO ; Ya-Ping YU ; Yong-Ping ZHAI
Journal of Experimental Hematology 2015;23(5):1357-1361
OBJECTIVETo investigate the clinical significance of serum free light chain (sFLC) detection in light chain multiple myeloma (LCMM).
METHODSA total of 37 newly diagnosed LCMM patients were enrolled in this study, including 17 patients with k light chain type and 20 patients with λ light chain type, the sFLC and 24 hours urine light chain (ULC) were measured before and after chemotherapy. The correlation of sFLC level with ULC and renal impairment was analyzed.
RESULTSAll the patients displayed an abnormally increased level of sFLC at diagnosis wtih median value of 105.44 mg/L and 146.39 mg/L for k and λ light chain types, respectively. The sFLC did not correlate with ULC before and after chemotherapy. Among the 12 patients with very good partial remission and normal ULC level, the sFLC still was abnormally increased in 8 patients. Renal impairment was associated with the urine λ-type light chain, and the area under the ROC curve of urine λ light chain at diagnosis is 0.792 (P = 0.031).
CONCLUSIONAll patients with LCMM show an abnormally increased level of sFLC at diagnosis. sFLC can be used to monitor the response to chemotherapy because it is more sensitive for analysis of therapeutic effect than urine λ light chain.
Humans ; Immunoglobulin Light Chains ; blood ; Immunoglobulin kappa-Chains ; blood ; Immunoglobulin lambda-Chains ; blood ; Multiple Myeloma ; blood ; drug therapy ; Renal Insufficiency
2.Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma.
Xiao-Bei MAO ; Xie-Qun CHEN ; Yong-Ping ZHAI ; Rong LIANG ; Guang-Xun GAO ; Guo-Guang MA ; Ya-Ping YU ; Feng LI
Journal of Experimental Hematology 2008;16(4):829-832
The objective of this study was to explore the clinical significance of measuring serum free light chains (sFLC) and to compare with serum total light chains (free and binded) in multiple myeloma (MM). sFLC in 20 newly diagnosed MM patients and 20 cases of healthy people as control were measured by immuno-nephelometric assays; the serum light chains and kappa/lambda ratio were measured in all patients, while immunofixation electrophoresis (IFE) tests were carried out at the same time in 18 out of 20 patients. The results showed that the abnormality of serum free light chains and kappa/lambda ratio were found in all of the 20 newly diagnosed MM patients (p < 0.01). The measurement of sFLC showed higher sensitivity than the total serum chains (p < 0.01). It is concluded that the method testing sFLC by immuno-nephelometric assay combined with kappa/lambda ratio is valuable for MM diagnosis, and the measurement of sFLC can be used as one of indicators for MM diagnosis.
Adult
;
Aged
;
Biomarkers, Tumor
;
blood
;
Female
;
Humans
;
Immunoglobulin kappa-Chains
;
blood
;
Immunoglobulin lambda-Chains
;
blood
;
Male
;
Middle Aged
;
Multiple Myeloma
;
blood
3.A Case of Multiple Myeloma Showing Marked Differences in Serum IgG Levels between Protein Electrophoresis and Turbidimetry.
Jeong Won SHIN ; Rojin PARK ; Tae Youn CHOI
The Korean Journal of Laboratory Medicine 2008;28(4):282-285
We report a case of multiple myeloma showing marked differences in serum Immunoglobulin G (IgG) levels between serum protein electrophoresis and turbidimetry. A 47-yr old man was admitted to our hospital due to severe back pain and diagnosed as having IgG-kappa type multiple myeloma. Serum protein level was 14.4 g/dL at the time of diagnosis. Serum IgG level was 8.5 g/dL by serum protein electrophoresis, but 11.6 g/dL by turbidimetry. The patient's clinical conditions had improved after receiving VAD (vincristine, adriamycin, dexamethasone) and VTD (vincristine, thalidomide, dexamethasone) chemotherapy and there were no differences in IgG levels between electrophoresis and turbidimetry when serum IgG levels were less than 3.0 g/dL. According to this, we considered that both protein electrophoresis and turbidimetry should be needed to quantify serum immunoglobulins for diagnosis and follow-up of the patients with monoclonal gammopathy.
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Electrophoresis, Agar Gel
;
Humans
;
Immunoglobulin G/*blood
;
Immunoglobulin kappa-Chains/blood
;
Male
;
Middle Aged
;
Multiple Myeloma/*diagnosis
;
Nephelometry and Turbidimetry
;
Paraproteinemias/drug therapy
;
Time Factors
4.Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer.
Nae Yu KIM ; Soo Jung GONG ; Jimyung KIM ; Seon Min YOUN ; Jung Ae LEE
The Korean Journal of Laboratory Medicine 2011;31(4):285-289
We report a rare case of multiple myeloma with biclonal gammopathy (IgG kappa and IgA lambda type) in a 58-year-old man with prostate cancer who presented with lower back pain. Through computed tomography (CT) imaging, an osteolytic lesion at the L3 vertebra and an enhancing lesion of the prostate gland with multiple lymphadenopathies were found. In the whole body positron emission tomography-computed tomography (PET-CT), an additional osteoblastic bone lesion was found in the left ischial bone. A prostate biopsy was performed, and adenocarcinoma was confirmed. Decompression surgery of the L3 vertebra was conducted, and the pathologic result indicated that the lesion was a plasma cell neoplasm. Immunofixation electrophoresis showed the presence of biclonal gammopathy (IgG kappa and IgA lambda). Bone marrow plasma cells (CD138 positive cells) comprised 7.2% of nucleated cells and showed kappa positivity. We started radiation therapy for the L3 vertebra lesion, with a total dose of 3,940 cGy, and androgen deprivation therapy as treatment for the prostate cancer.
Adenocarcinoma/complications/*diagnosis/radiotherapy
;
Antineoplastic Agents/therapeutic use
;
Bone Marrow Cells/metabolism/pathology
;
Combined Modality Therapy
;
Humans
;
Immunoelectrophoresis
;
Immunoglobulin kappa-Chains/blood
;
Immunoglobulin lambda-Chains/blood
;
Male
;
Middle Aged
;
Multiple Myeloma/complications/*diagnosis/drug therapy
;
Neoplasm Staging
;
Positron-Emission Tomography
;
Prostatic Neoplasms/complications/*diagnosis/radiotherapy
;
Spine/pathology
;
Syndecan-1/metabolism
;
Tomography, X-Ray Computed
5.A Case of Primary Gastric Amyloidosis with Fulminant Heart Failure.
Seonghun HONG ; Young Woon CHANG ; Jong Kyu BYUN ; Min Je KIM ; Jung Min CHAE ; Sun Hee PARK ; Chi Hyuk OH ; Yong Koo PARK
The Korean Journal of Gastroenterology 2015;66(4):227-230
A 53-year-old woman was admitted with epigastric discomfort and weakness. Laboratory examination at admission showed mild anemia and proteinuria. Esophagogastroduodenoscopy revealed marked mucosal atrophy, diffuse nodularity and granular appearance with mucosal friability. Biopsy was performed on the antrum and body of the stomach. On the next day, the patient began to complain of severe dyspnea, and hypoxia was present on pulse oximetry. Therefore, emergency echocardiography was conducted and it showed restrictive cardiomyopathy along with thrombus in the left atrium. With time, heart failure was aggravated despite intensive management. The result of gastric biopsy revealed amyloid deposits which stained positively with Congo red. On immunohistochemistry study, kappa and lambda chain were present. In addition, kappa chain was significantly elevated in urine and serum on electrophoresis. Although the patient was finally diagnosed as having primary gastric amyloidosis with restrictive cardiomyopathy, her general condition rapidly deteriorated and died at 12th hospital day. When obscure gastric lesion is encountered, performing gastric biopsy is strongly recommended since it be primary gastric amyloidosis. Herein, we present an unusual case of primary gastric amyloidosis.
Amyloidosis/complications/*diagnosis/pathology
;
Endoscopy, Digestive System
;
Female
;
Heart Atria/diagnostic imaging
;
Heart Failure/complications/*diagnosis
;
Humans
;
Immunoglobulin kappa-Chains/blood/urine
;
Immunoglobulin lambda-Chains/blood/urine
;
Immunohistochemistry
;
Magnetic Resonance Imaging
;
Middle Aged
;
Stomach Diseases/complications/*diagnosis/pathology
;
Thrombosis/diagnosis/diagnostic imaging
;
Tomography, X-Ray Computed
;
Ultrasonography
6.Length diversity in CDR3 Domain of Immunoglobulin Kappa Chain during the Human Deelopment.
Ji Soo LEE ; Soo Kon LEE ; Chan Hee LEE ; Chang Ho SONG
Korean Journal of Immunology 1998;20(3):309-316
The third complementarity determining region (CDR3) of the immunoglobulin (Ig) kappa () chain is known to be located at the center of antigen binding groove and critical for antibody specificity. Ig chain has been characterized by limited junctional diversity due to the absence of N-region addition resulting in relative conservation of CDR3 lengths with 9 or 10 amino acids. CDR3 region of 11 amino acids is only possible with N-region addition. Recently, x transcripts with 11 amino acids CDR3 was found to be expressed in normal individuals, and in autoimrnune disease such as rheumatoid arthritis, the fraction of 11 amino acids CDR3 of humkv325-derived chains was overexpressed compared to conventional adult peripheral B cells. However, the significance of this bias is difficult to interpret without a clear understanding of normal repertoire of CDR3 length during development. The purpose of this study is to determine whether developmental regulation of CDR3 amino acids codon lengths exists in chains expressed in the fetal liver, cord blood, and adult peripheral blood lymphocytes (PBL). Lymphocytes were seperated from fetal liver, cord blood and adult PBL and cDNA was generated from extracted mRNA. PCR-based CDR3 finger- printing assay was performed with VI-IV family specific primers. CDR3 length diversity of Ig x chain increases as the development proceeds. The length diversity most frequently occured in Vlll family derived transcripts including 11 amino acids CDR3. transcripts with 11 amino acids CDR3 were consitently expressed in both fetal and adult Ig repertoire. These results support the hypothesis that v chain CDR3 length is developmentally regulated and implicates the diversity of antigen-antibody specificity generation.
Adult
;
Amino Acids
;
Antibody Specificity
;
Arthritis, Rheumatoid
;
B-Lymphocytes
;
Bias (Epidemiology)
;
Codon
;
Complementarity Determining Regions
;
DNA, Complementary
;
Fetal Blood
;
Humans*
;
Immunoglobulin kappa-Chains*
;
Immunoglobulins*
;
Liver
;
Lymphocytes
;
RNA, Messenger
;
Sensitivity and Specificity
7.Monitoring changes of serum protein markers in metastatic colorectal carcinoma model.
Zu-guo LI ; Liang ZHAO ; Li LIU ; Yan-qing DING
Chinese Journal of Pathology 2007;36(1):48-52
OBJECTIVETo investigate the changes of several protein markers in a metastatic colorectal carcinoma model by serum proteomic analysis.
METHODSThe pEGFP-N1 plasmid with enhanced expression of green fluorescence protein (EGFP) was transfected into human colon carcinoma cell line SW480 to obtain a stable SW480-EGFP cell line, the SW480-EGFP cells were then injected subcutaneously into nude mice. The harvested tumor cells were implanted orthotopically into the colon of the nude mice. Real-time tumor growth and metastasis formation were visualized by whole-body fluorescent imaging system. Serum samples at different metastatic stages were collected and differential proteomic profiles were investigated by two-dimensional gel electrophoresis (2DE) and matrix-assisted laser absorption/ionization time of flight mass spectrometry (MALDI-TOF MS).
RESULTSThe SW480- EGFP cells enabled to express EGFP stably. The rates of subcutaneous and orthotropic tumor formation were 100%. The metastasis rates to local lymph nodes, liver and lung were 100%, 40% and 30%, respectively. Furthermore, 5 differentially expressed proteins were analyzed by serum proteome technologies, including haptoglobin alpha chain, apolipoprotein E, apolipoprotein A-IV, Ig kappa chain V region chain L and transferrin.
CONCLUSIONSVisualized metastatic model of colorectal carcinoma was successfully established. Several differentially expressed serum proteins collected at different stages after the occurrence of metastasis were identified. These differentially expressed proteins may be candidate serum biomarkers for diagnosis and therapeutic evaluation of colorectal carcinoma metastasis.
Animals ; Apolipoproteins A ; blood ; Apolipoproteins E ; blood ; Biomarkers, Tumor ; blood ; Blood Proteins ; analysis ; Cell Line, Tumor ; Colorectal Neoplasms ; blood ; genetics ; pathology ; Electrophoresis, Gel, Two-Dimensional ; Green Fluorescent Proteins ; genetics ; metabolism ; Haptoglobins ; analysis ; Humans ; Immunoglobulin kappa-Chains ; blood ; Liver Neoplasms ; secondary ; Lung Neoplasms ; secondary ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Transplantation ; Neoplasms, Experimental ; blood ; genetics ; pathology ; Proteomics ; methods ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Transfection ; Transferrin ; analysis ; Transplantation, Heterologous